University of York uses G:BOX Imaging System
News Jun 01, 2010
Syngene announces a G:BOX chemiluminescence imaging system is being used at the University of York as a fast, affordable method to determine expression of a wide range of proteins on chemiluminescent Western blots.
Scientists in the Technology Facility at the University of York are using a G:BOX chemiluminescence imaging system to image Western blots stained with alkaline phosphatase to screen new constructs for protein expression. This imaging ensures researchers in the facility can demonstrate that recombinant clones are expressing the correct proteins and deliver them to other scientists for use in their studies.
Dr Jared Cartwright, a Laboratory Head in the Technology Facility explained: “We run a protein production service for researchers at York and other universities and to make this facility cost-efficient we have to use detection techniques with our Western blots which will identify the target proteins. Additionally, we have to analyse the results rapidly so using autoradiography was becoming too time consuming, expensive and presented issues with the incorporation of data in reports and publications.”
Dr Cartwright added: “To overcome these problems we assessed three different CCD imaging systems to determine which would best suit our range of applications. We found the G:BOX’s image capture and analysis software were simple to use and the quality of data was more precise than we previously obtained with autoradiography. As a result, we installed the system in 2008 and have been happy with its performance ever since.”
‘Good Cholesterol’ May Not Always be Good for Postmenopausal WomenNews
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) – also known as ‘good cholesterol’ – according to a study led by researchers in the University of Pittsburgh Graduate School of Public Health.READ MORE
What Makes Good Brain Proteins Turn Bad?News
The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.